50 results
8-K
EX-99.1
CNSP
Cns Pharmaceuticals Inc
12 Apr 24
Regulation FD Disclosure
6:37pm
at Novartis. CHIEF MEDICAL OFFICER Sandra L. Silberman, MD, PhD Nearly 20 years of finance and investment banking experience primarily in the healthcare … roles in a variety of healthcare companies. Recently Mr. Climaco served as the Executive Vice - President of Perma - Fix Medical S.A where he managed
8-K
EX-99.1
CNSP
Cns Pharmaceuticals Inc
1 Apr 24
Berubicin study enrollment completed; Topline data expected in first half of 2025
5:01pm
closed a $4.0 million public offering with participation from healthcare-focused institutional investors, retail investors, and certain officers
424B4
CNSP
Cns Pharmaceuticals Inc
31 Jan 24
Prospectus supplement with pricing info
4:27pm
Executive Officer. Mr. Climaco has served in leadership roles in a variety of healthcare companies. From April 2015 to June 2017 Mr. Climaco served … of Digirad Corporation, a publicly traded healthcare services and medical device company. From August 2011 until September 2012, Mr. Keyes
8-K
EX-99.1
5z8rok11swd0hj24d
10 Jan 22
Regulation FD Disclosure
9:25am
8-K
EX-99.1
ts5 yt03z8p
3 Dec 21
Regulation FD Disclosure
4:08pm
8-K
EX-99.1
07a6a1
19 Jul 21
Regulation FD Disclosure
7:48am
PRE 14A
m580yyr cxj
27 May 21
Preliminary proxy
5:17pm
8-K
EX-99.1
dl4iq6ksifv9 5wid
18 May 21
Regulation FD Disclosure
4:03pm
8-K
EX-99.1
uifibuz5jck9cp
17 Mar 21
Regulation FD Disclosure
7:50am